Cervantes, Georgen G.

HRN: 03-11-71  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/21/2026
COTRIMOXAZOLE 960MG (TAB)
05/21/2026
06/04/2026
PO
160/800mg
MWF
Immunocompromised Host
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Prophylaxis    Compliance to guidelines: